Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
Clinical trial NCT04747613 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04747613
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-27
- Primary completion
- 2027-10-18
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.